{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:50:40Z","timestamp":1791103840968,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007961","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T00:00:00Z","timestamp":1339545600000}}],"reference-count":46,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007961.pub2","type":"journal-article","created":{"date-parts":[[2012,6,8]],"date-time":"2012-06-08T15:04:54Z","timestamp":1339167894000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Topical microbicides for prevention of sexually transmitted infections"],"prefix":"10.1002","author":[{"given":"Jael","family":"Obiero","sequence":"first","affiliation":[{"name":"University of Nairobi; Institute of Primate Research; Nairobi Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G","family":"Mwethera","sequence":"additional","affiliation":[{"name":"Institute of Primate Research; Head, Reproductive Health & Biology; P.O.Box 24481 Karen 00502 Nairobi Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Shey","family":"Wiysonge","sequence":"additional","affiliation":[{"name":"University of Cape Town; Institute of Infectious Disease and Molecular Medicine & Division of Medical Microbiology; Anzio Road Observatory South Africa 7925"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,6,13]]},"reference":[{"key":"10.1002\/14651858.CD007961.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir Gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1745-6215-12-67","article-title":"Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial","volume":"12","author":"Karim","year":"2011","journal-title":"Trials"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0003|cit3","unstructured":"Keller DM AIDS 2010, XVIII International AIDS Conference: Tenofovir vaginal gel first microbicide to prevent HIV, HSV infections Medscape Medical News July 2010"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/QAD.0b013e32834541d9","article-title":"Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women","volume":"25","author":"Abdool Karim","year":"2011","journal-title":"AIDS"},{"issue":"1","key":"10.1002\/14651858.CD007961.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1371\/journal.pone.0001474","article-title":"SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria","volume":"3","author":"Feldblum","year":"2008","journal-title":"PLoS One"},{"issue":"11","key":"10.1002\/14651858.CD007961.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"e3784","DOI":"10.1371\/journal.pone.0003784","article-title":"Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: r esults of a phase III trial in Nigeria","volume":"3","author":"Halpern","year":"2008","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(10)61086-0","article-title":"PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial","volume":"376","author":"McCormack","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD007961.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1371\/journal.pone.0001312","article-title":"SAVVY (C31G) gel for prevention of HIV infection in women: a phase 3, double-blind, randomized, placebo-controlled trial in Ghana","volume":"2","author":"Peterson","year":"2007","journal-title":"PLoS One"},{"issue":"8","key":"10.1002\/14651858.CD007961.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3851\/IMP1890","article-title":"The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection","volume":"16","author":"Marais","year":"2011","journal-title":"Antiviral Therapy"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0140-6736(08)61842-5","article-title":"Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Skoler-Karpoff","year":"2008","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1056\/NEJMoa0707957","article-title":"Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission","volume":"359","author":"Damme","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/01.olq.0000175404.18098.dd","article-title":"A randomized trial of clinician-delivered interventions promoting barrier contraception for sexually transmitted disease prevention","volume":"32","author":"Artz","year":"2005","journal-title":"Sexually Transmitted Diseases"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0013|cit13","first-page":"1660","article-title":"Acceptability and feasibility of a clinical trial to assess the efficacy of a microbicide-containing vaginal gel to prevent HIV infection among female sex workers in Abidjan, Cote d'Ivoire","volume":"11","author":"Etti\u00e8gne-Traor\u00e9","year":"1997","journal-title":"AIDS"},{"issue":"5","key":"10.1002\/14651858.CD007961.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0015-0282(02)04210-3","article-title":"Use of mandelic acid condensation polymer (SAMMA), a new antimicrobial contraceptive agent, for vaginal prophylaxis","volume":"78","author":"Zaneveld","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00007435-198707000-00005","article-title":"The contraceptive sponge's protection against Chlamydia trachomatis and Neisseria gonorrhea","volume":"14","author":"Rosenberg","year":"1987","journal-title":"Sexually Transmitted Diseases"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.contraception.2007.07.004","article-title":"A randomized controlled safety trial of the diaphragm and cellulose sulphate microbicide gel in sexually active women in Zimbabwe","volume":"76","author":"Straten","year":"2007","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0017|cit17","unstructured":"NCT00705679 Safety and e ffectiveness of t enofovir 1% g el, t enofovir d isproxil f umarate, and e mtricitabine\/t enofovir d isoproxil f umarate t ablets in p reventing HIV in w omen Clinicaltrials.gov\/show\/NCT00705679"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0018|cit18","unstructured":"NCT01386294 Safety and effectiveness of tenofovir gel in the prevention of human immunodeficiency virus (HIV-1) infection in young women and the effects of tenofovir gel on the incidence of herpes simplex virus (HSV-2) infection Clinicaltrials.gov\/show\/NCT01386294"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0019|cit19","unstructured":"AVAC (Gloabal Advocacy for HIV Prevention) VOICE trial changes are disappointing, but do not close the door on PrEP for women; c ontinued PrEP research more important than ever AVAC Press Release"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0140-6736(04)15881-9","article-title":"Marvellous microbicides. Intravaginal gels could save millions of lives, but first someone has to prove that they work","volume":"362","author":"Brown","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.antiviral.2009.10.013","article-title":"Development of topical microbicides to prevent the sexual transmission of HIV","volume":"85","author":"Buckheit","year":"2010","journal-title":"Antiviral Research"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(08)70254-8","article-title":"Vaginal microbicides and the prevention of HIV transmission","volume":"8","author":"Cutler","year":"2008","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1381612043386374","article-title":"Clinical development of microbicides for prevention of HIV infection","volume":"10","author":"D'Cruz","year":"2004","journal-title":"Current Pharmaceut ical Design"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002030-199401000-00002","article-title":"Challenges for the development of female-controlled vaginal microbicides","volume":"8","author":"Elias","year":"1994","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0026|cit26","first-page":"393","article-title":"Microbicides for preventing HIV infection could be available by 2010","volume":"82","author":"Fleck","year":"2004","journal-title":"Bulletin World Health Organization"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/095632020901900401","article-title":"The future of HIV microbicides: challenges and opportunities","volume":"19","author":"Garg","year":"2009","journal-title":"Antiviral Chemistry & Chemotherapy"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: i ntroduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiolo gy"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/374834","article-title":"Topical microbicides for disease prevention: status and challenges","volume":"30","author":"Harrison","year":"2003","journal-title":"Journal of Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/154099903321667591","article-title":"A pilot study of treatment of bacterial vaginosis with a buffering vaginal microbicide","volume":"12","author":"Harwell","year":"2003","journal-title":"Journal of Women's Health"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0031|cit31","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1128\/AAC.50.3.1063-1066.2006","article-title":"Inactivation of herpes simplex virus clinical isolates by using a combination microbicide","volume":"50","author":"Isaacs","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev.med.59.061206.112737","article-title":"Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission","volume":"59","author":"Klasse","year":"2008","journal-title":"Annual Review of Medi cine"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(06)69482-8","article-title":"Global control of sexually transmitted infections","volume":"368","author":"Low","year":"2006","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0035|cit35","first-page":"174","article-title":"Antichlamydial activity of vaginal secretion","volume":"80","author":"Mahmoud","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3851\/IMP1890","article-title":"The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection","volume":"16","author":"Marais","year":"2011","journal-title":"Antiviral Therapy"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1086\/318496","article-title":"Safety and tolerability of BufferGel, a n ovel vaginal microbicide, in women in the United States","volume":"32","author":"Mayer","year":"2001","journal-title":"Journal of Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0038|cit38","first-page":"1231","article-title":"Microbicides in the prevention of HIV infection: current status and future directions","volume":"70","author":"Nuttall","year":"2010","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1097\/00002030-200011100-00018","article-title":"Challenges in the conduct of vaginal microbicide effectiveness in the developing world","volume":"14","author":"Ramjee","year":"2000","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0002-9378(86)90108-0","article-title":"Personal protection against sexually transmitted diseases","volume":"155","author":"Stone","year":"1986","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd959","article-title":"Microbicides: a new approach to preventing HIV and other sexually transmitted infections","volume":"1","author":"Stone","year":"2002","journal-title":"Nature Review Drug Discovery"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0042|cit42","unstructured":"UNAIDS Global report: UNAIDS report on the global AIDS epidemic 2010. UNAIDS\/10.11E\/JC1958E Joint United Nations Programme on HIV\/AIDS. Geneva"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00042560-200101010-00003","article-title":"Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites","volume":"26","author":"Wijgert","year":"2001","journal-title":"Journal of Acquired Immune Deficiency Syndrome"},{"issue":"1","key":"10.1002\/14651858.CD007961.pub2-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003939","article-title":"Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men","author":"Wilkinson","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007961.pub2-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003936","article-title":"Nonoxynol-9 for preventing vaginal acquisition of HIV infection by women from men","author":"Wilkinson","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007961.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00007435-200107000-00010","article-title":"Test of BufferGel for contraception and prevention of sexually transmitted diseases in animal models","volume":"28","author":"Zeitlin","year":"2001","journal-title":"Sexually Transmitted Diseases"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007961.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007961.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:15:40Z","timestamp":1628547340000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007961.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane STI Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,13]]},"references-count":46,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007961.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD007961.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,13]]}}}